Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The HIV envelope protein gp120 is a glycoprotein found on the surface of the Human Immunodeficiency Virus (HIV) envelope. It plays a critical role in viral entry into host cells by mediating attachment to specific cell surface receptors. Gp120 binds primarily to CD4 receptors on helper T-cells but can also interact with DC-SIGN and heparan sulfate proteoglycans. This binding initiates conformational changes necessary for subsequent interaction with chemokine co-receptors (CCR5 or CXCR4), leading to membrane fusion mediated by gp41. Gp120 has an inner domain and an outer domain bridged by a four-stranded antiparallel β-sheet. Gp120 is heavily glycosylated with N-linked glycans that form a "glycan shield," protecting it from immune recognition. Three molecules each of gp120 associate noncovalently with three molecules each of transmembrane protein gp41 to form functional Env spikes on HIV's surface. Variable regions sterically hinder antibody access; conserved neutralizing epitopes are recessed or masked by glycans or variable loops. This structural plasticity allows evasion from broadly neutralizing antibodies despite being immunogenic itself.
N/A
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on HIV Envelope Protein gp120 (gp120).